Skip to Main Content

Last week a study showing that immunotherapies may lead to rapid tumor growth in a small subset of patients met with some concern among oncologists and researchers. They worried that the news could dampen enthusiasm surrounding cancer’s most promising new therapy.

Indeed, some of the researchers who observed the effect expressed hesitancy about sharing the news widely.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

Comments are closed.